Parkinson’s Foundation researchers and other scientists worldwide make continual advances in understanding Parkinson’s disease (PD) with revolutionary research. We monitor it all in our effort to improving care and advance research toward a cure. Browse our collection here:
A drug used for treating liver disease shows potential as a therapy for slowing the progression of a genetic form of Parkinson’s disease (PD), according to research published in the August 7 online edition of Neurology. In experiments with cells and fruit flies, the drug reversed cellular damage caused by a mutation in the geneknown as LRRK2.